All clinical trial organizers consider the safety of trial participants as a top priority. Therefore, each phase of the trial follows strict scientific standards.
IRBs are committees designated to review and monitor clinical trials involving human subjects. An IRB has the authority to approve the methods and techniques for conducting a clinical trial, require changes to a trial protocol, or disapprove any trial that poses risk to participants. Every clinical study in the United States must be approved by an Institutional Review Board.
The primary goal of an IRB is to protect the rights and safety of clinical trial participants.
A Data Safety Monitoring Board is a group of experts who are not involved in the trial. They are independent of the trial organizers.
DSMBs provide data analysis of clinical trial data and inform the sponsor about the safety of participants, hidden risks, and scientific validity of the trial. Almost every Phase III clinical trial has a Data Safety Monitoring Board. This board is comprised of a panel of research and study topic experts.
The Food and Drug Administration regulates research that involves new drugs and medical devices. The FDA also reviews applications for new medicines before any testing on humans is done. It requires that informed consent be obtained from all subjects of clinical trials. The FDA provides supervision and guidance during different phases of a clinical trial.
Informed consent includes detailed information about the purpose and course of a clinical trial. Potential trial participants should be given adequate time to make a decision and sign an informed consent. There is a list of set questions to ask the study coordinator and make sure that the participant is properly and correctly informed.● Purpose of the trial.
Potential participants can take the informed consent and consult with their doctor about the pros and cons of participation in the study.